Browsing by Author Geyer, Charles

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2015Adjuvant ovarian suppression in premenopausal breast cancerCoates, Alan; Bellet, Meritxell; Bonnefoi, Herve; Buchholz, Stefan; Burstein, Harold; Ciruelos, Eva; Climent, Miguel; Coleman, Richard; Colleoni, Marco; Da Prada, Gian; Davidson, Nancy; Fleming, Gini; Francis, Prudence; Gelber, Richard D. (Prof); Geyer, Charles; Giobbie-Hurder, Anita; Goldhirsch, Aron (Prof); Ingle, J.; Kerbrat, Pierre; Lang, Istvan; Maibach, Rudolph; Martino, Silvana; Price, K. N; Rabaglio-Poretti, Manuela; Regan, Meredith; Ruepp, Barbara; Viale, Giuseppe; Walley, Barbara; Winer, EP; School of Public Health: Public HealthAdjuvant ovarian suppression in premenopausal breast cancer, The New England Journal of Medicine, vol.372, 5, 2015,pp 436-446
2017Poor Prognosis After Second Locoregional Recurrences in the CALOR TrialCoates, Alan; Anderson, Stewart; et al, Various; Gelber, Shari; Geyer, Charles; Mamounas, Eleftherios; Martin, Miguel; Nortier, Johan; Paterson, Alexander; Robidoux, Andre; Wapnir, Irene L.; NH&MRC Clinical Trials CentrePoor Prognosis After Second Locoregional Recurrences in the CALOR Trial, Annals of Surgical Oncology, vol.24, 2, 2017,pp 398-406
2016Serum human epidermal growth factor 2 extracellular domain as a predictive biomarker for lapatinib treatment efficacy in patients with advanced breast cancerDavies, Lucy; Gebski, Val; Lee, Chee Khoon; Lord, Sarah (Sally); Marschner, Ian; Simes, Robert John; Cameron, David; de Souza, Paul; Di Leo, Angelo; Ellis, Catherine; Geyer, Charles; Johnston, Stephen; Loi, Sherene; Press, Michael F.; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreSerum human epidermal growth factor 2 extracellular domain as a predictive biomarker for lapatinib treatment efficacy in patients with advanced breast cancer, Journal of Clinical Oncology, vol.34, 9, 2016,pp 936-944